http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1009401-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_58b168c77e8d602ed5ad1eba022b76cc http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7a90597b8e0527c4b450235322359da2 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 1998-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c1cbf155f4c82c5cbfb1d43654a52b6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_307a08babe4d0b530951692a9e07b393 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69884dd85f3ee479f604712d1a4164e7 |
publicationDate | 2000-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-1009401-A1 |
titleOfInvention | Dithiolopyrrolones and their corresponding monoxides and dioxides as antineoplastic agents |
abstract | Compounds, isolated from the bacteria Xenorhabdus bovienii, having formula (1), wherein R1 = hydrogen, substituted or unsubstituted alkyl, cycloalkyl, aryl, aralkyl, or heterocyclyl group; R2 = hydrogen, substituted or unsubstituted alkyl, cycloalkyl, aryl, aralkyl, heterocyclyl or group acyl; R3 = hydrogen, alkyl, cycloalkyl, aralkyl, aryl or heterocyclyl group, or (2), wherein R1 = hydrogen, substituted or unsubstituted alkyl, cycloalkyl, aryl, aralkyl, or heterocyclyl group; R2 = hydrogen, substituted or unsubstituted alkyl, cycloalkyl, aryl, aralkyl, heterocyclyl or group acyl; R3 = hydrogen, alkyl, cycloalkyl, aralkyl, aryl or heterocyclyl group, or (3), wherein R1 = hydrogen, substituted or unsubstituted alkyl, cycloalkyl, aryl, aralkyl, or heterocyclyl group; R2 = hydrogen, substituted or unsubstituted alkyl, cycloalkyl, aryl, aralkyl, heterocyclyl or group acyl; R3 = hydrogen, alkyl, cycloalkyl, aralkyl, aryl or heterocyclyl group or the salts thereof have antineoplastic activity. The invention provides pharmaceutical compositions containing the compounds and the methods for employing them as medicaments, particularly in the treatment of human and animal cancers. |
priorityDate | 1997-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 319.